Condition
Lung Transplant; Infection or Inflammation
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Active Sponsors
- Duke University1
- National Heart, Lung, and Blood Institute (NHLBI)1
- University of Pennsylvania1
Top Investigators
University of Pennsylvania
Duke University School of Medicine, Department of Medicine
Duke University School of Medicine, Department of Biostatistics and Bioinformatics
Related Conditions
- Lung Transplant Rejection1
- Lung Transplant Complications1
- Lung Transplant Failure1